Webinar Available on Demand

Cytokine Based Drug Development Landscape

Taking a deep dive into the cytokine-based drug development landscape, this session provided a comprehensive analysis of the current pipeline as well as a detailed look into 2023 and beyond.

Cytokine Based Drug Development Webinar

Despite some high-profile setbacks and dropped assets, the cytokine drug-development landscape continues to flourish. In our exclusive webinar, our expert panel delved into the landscape, showcased the shift in targets, and assessed the effect of the continued challenges being faced by drug developers, to provide an extensive analysis of the dynamic landscape. Key aspects explored included:

A comprehensive overview of the evolving landscape, including cytokines as monotherapies and in combinations

Insights into the emerging trends of interleukin targets, including IL-2, IL-7, and IL-12

A picture of what we can likely expect ahead based on drugs that have been translated into the clinic so far this year.

Our Experts

Aysha Saeed

 

House Speaker

Lead Research Analyst

Beacon

Priya Soneji

 

Moderator

Account Manager

Beacon

You May Also Be Interested In…

Learn More About Cytokine

What is Beacon Cytokine?
  • The Most Comprehensive Way to Search the Cytokine Drug Development Landscape: Unique search ontologies based on Cytokine drug and trial characteristics
  • Market Leading Approach to Cytokine Preclinical & Clinical Data Curation: Manual curation of key Cytokine research and development data points by Cytokine research scientists
  • Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Cytokine company and deal data based on their pipeline and technologies.
  • Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
Learn More About Beacon Cytokine Request Demo

What is Beacon?

Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.

Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.

This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.

We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!

Request Demonstration

Menu
Search Icon
Close Icon
Search